Report Calls for Initiative to Establish a World-leading UK Microbiome Biobank We’re pleased to announce the release of a new NBIC-facilitated report from CABI Agriculture and Bioscience. The report calls for a “highly ambitious enterprise” to create a microbiome...
Innovative Businesses Secure Funding After Completing LYVA Labs’ Microbials Accelerator Programme Nine innovative businesses are celebrating receiving £857,000 in funding, from the Innovate UK Biomedical Catalyst feasibility grant, after completing LYVA Labs’...
NBIC Research Paper: Identification of Priority Questions in Biofilm Research, Innovation and Policy In a significant step towards addressing the global challenges posed by microbial biofilms, a new collaborative research paper titled ‘Global Challenges and Microbial...
NBIC Deliver Technical Module: Surfaces and Materials meet Biofilms The NBIC Doctoral Training Centre in Biofilms Innovation, Technology, and Engineering (BITE) along with the Open Innovation Hub for Antimicrobial Surfaces (OPIHAS), at the University of Liverpool,...
Target Product Profiles for Diagnostics The Cystic Fibrosis (CF) Antimicrobial Resistance (AMR) Syndicate recently launched their diagnostic target product profiles (TPPs) detailing key characteristics of new tests needed to detect and manage lung infections in CF. A...
